Wednesday, September 03, 2014

Mapp Biopharmaceuticals needs whatever support is required to continue to develop and produce its miracle drug.

ZMapp is an intravenous composed of three separate monoclonal antibodies. I am quite certain it is very expensive to make and grants, donations and government support is required. But, this has to go forward while other measures are investigated as a vaccine. 

ZMapp is passive immunity. If there was enough of the drug to go around it would wipe out the current epidemic before it spreads any further. That would be the best outcome for a very expensive medication. 

I did note during the address by Nancy Writebol she was treated with an anti-malarial drug before the ZMapp was administered. It might be interesting to at least administer anti-malarial medications in the meantime to find it's effectiveness in the absence of ZMapp. 

Vaccines are funny things. Anti-virals can stimulate the immune system even if the target of the anti-viral is not being treated. I can't help but wonder if the anti-malarial stimulated the immune system 'enough' to bring about a better outcome.

”Whitenicious” Entrepreneur, Dencia (click here) has launched an appeal to raise $1,000,000 for the purchase of Z-Mapp - the experimental Ebola drug made in the US for Africans who are affected by the Ebola epidemic.
Although the manufacturers of Z-Mapp have said that the current stock of the drug is finished, Dencia is bent on raising the funds maybe to encourage the manufacturers to produce a new batch to help fight the virus.
In the video, Dencia shares her childhood health struggles as well as her current fears that Ebola is “just a flight away”.